Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma

Mohamed Alsharedi

Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma

Mohamed Alsharedi

Marshall University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	BMJ Case Reports
State	Published - Sep 13 2016

Disciplines

Medicine and Health Sciences

Cite this

@article{2c55a37c9a5c4fe8b602603aa7ce0a43,

title = "Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma",

author = "Mohamed Alsharedi",

note = "Recent advances in novel immunotherapeutic and targeted therapeutic agents have increased treatment options in patients with advanced metastatic melanoma. However, evidence in the literature on whether or not extracutaneous melanoma will acquire an equivalent advantage from these therapies is very scarce.",

year = "2016",

month = sep,

day = "13",

language = "American English",

journal = "BMJ Case Reports",

}

TY - JOUR

T1 - Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma

AU - Alsharedi, Mohamed

N1 - Recent advances in novel immunotherapeutic and targeted therapeutic agents have increased treatment options in patients with advanced metastatic melanoma. However, evidence in the literature on whether or not extracutaneous melanoma will acquire an equivalent advantage from these therapies is very scarce.

PY - 2016/9/13

Y1 - 2016/9/13

UR - http://casereports.bmj.com/content/2016/bcr-2016-216450.abstract

M3 - Article

JO - BMJ Case Reports

JF - BMJ Case Reports

ER -

Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma

Disciplines

Other files and links

Cite this